Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint
inflammation which ultimately leads to severe disability and premature mortality. It has a …

OBJECTIVES: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with
increasing disability, reduced quality of life and substantial costs (as a result of both …

Background A prolonged symptom or disease duration at treatment initiation is associated
with unfavourable outcomes in rheumatoid arthritis (RA). It is unknown whether this relation …

Objective. The Canadian Rheumatology Association (CRA) has developed
recommendations for the pharmacological management of rheumatoid arthritis (RA) with …

Objectives. Rheumatoid arthritis (RA) associates with excessive cardiovascular morbidity
and mortality. Hypertension (HT) contributes significantly to the development of …

Objectives To investigate the effect of group cognitive behavioural therapy (CBT) for fatigue
self-management, compared with groups receiving fatigue information alone, on fatigue …

Managing pain from chronic conditions, such as, but not limited to, osteoarthritis and
rheumatoid arthritis, requires the clinician to balance the need for effective analgesia against …

Aims Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1%
of the world's population. There are a wide number of guidelines and recommendations …

Summary Abstract Tocilizumab (RoActemra® or Actemra®) is a recombinant humanized
monoclonal antibody that acts as an interleukin (IL)-6 receptor antagonist. Intravenous …

Objective There is evidence supporting a therapeutic range for methotrexate polyglutamate
(MTXGlu) concentrations in the treatment of rheumatoid arthritis (RA). Knowledge of the …